Clinical trial
Defeat Rare Disease in Asia and Pacific (APAC) DRDA - Haemophilia
NCT07163260 is registered in ClinicalTrials.gov with Novo Nordisk A/S as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Defeat Rare Disease in Asia and Pacific (APAC) DRDA - Haemophilia
- Lead sponsor
- Novo Nordisk A/S
- Phase
- Observational
- Overall status
- Enrolling by invitation
- Start date
- January 31, 2025
- Completion date
- December 19, 2025
- Enrollment
- 244 (estimated)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
haemophilia